Skip to main content
Top
Published in: Acta Diabetologica 9/2018

01-09-2018 | Original Article

The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes

Authors: Sunee Saetung, Hataikarn Nimitphong, Nantaporn Siwasaranond, Rungtip Sumritsopak, Panitha Jindahra, Orapitchaya Krairit, Ammarin Thakkinstian, Thunyarat Anothaisintawee, Sirimon Reutrakul

Published in: Acta Diabetologica | Issue 9/2018

Login to get access

Abstract

Aims

Diabetes is linked to cognitive impairment. Sleep plays a role in memory consolidation. Sleep disturbances, commonly found in patients with diabetes, were shown to be related to cognitive dysfunction. This study explored the role of sleep in cognitive function of patients with abnormal glucose tolerance.

Methods

A total of 162 patients (81 type 2 diabetes and 81 prediabetes) participated. Sleep duration and sleep efficiency (an indicator of sleep quality) were obtained using 7-day actigraphy recordings. Obstructive sleep apnea (OSA) was screened using an overnight in-home monitor. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA). Three sub-scores of MoCA, visuoexecutive function, attention and delayed recall, were also analyzed.

Results

Mean age was 54.8 (10.2) years. OSA was diagnosed in 123 participants (76.9%). Mean sleep duration was 6.0 (1.0) h and sleep efficiency was 82.7 (8.1) %. Sleep duration and OSA severity were not related to MoCA scores. Higher sleep efficiency was associated with higher MoCA scores (p = 0.003), and having diabetes (vs. prediabetes) was associated with lower MoCA scores (p = 0.001). After adjusting covariates, both having diabetes (vs. prediabetes) (B = − 1.137, p = 0.002) and sleep efficiency (B = 0.085, p < 0.001) were independently associated with MoCA scores. In addition, diabetes (B = − 0.608, p < 0.001) and sleep efficiency (B = 0.038, p < 0.001) were associated with visuoexecutive function. Sleep parameters were not related to delayed recall or attention scores.

Conclusion

Lower sleep efficiency is independently associated with lower cognitive function in patients with abnormal glucose tolerance. Whether sleep optimization may improve cognitive function in these patients should be explored.
Literature
2.
go back to reference American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, Fifth Edition (DSM-5). American Psychiatric Publishing, Washington, D.C.CrossRef American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, Fifth Edition (DSM-5). American Psychiatric Publishing, Washington, D.C.CrossRef
4.
go back to reference Manschot SM, Brands AM, van der Grond J et al (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55:1106–1113CrossRefPubMed Manschot SM, Brands AM, van der Grond J et al (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55:1106–1113CrossRefPubMed
5.
go back to reference Grodstein F, Chen J, Wilson RS, Manson JE (2001) Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24:1060–1065CrossRefPubMed Grodstein F, Chen J, Wilson RS, Manson JE (2001) Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24:1060–1065CrossRefPubMed
12.
go back to reference Cukierman-Yaffe T, Gerstein HC, Williamson JD et al (2009) Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32:221–226. https://doi.org/10.2337/dc08-1153 CrossRefPubMedPubMedCentral Cukierman-Yaffe T, Gerstein HC, Williamson JD et al (2009) Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32:221–226. https://​doi.​org/​10.​2337/​dc08-1153 CrossRefPubMedPubMedCentral
26.
go back to reference Boland LL, Shahar E, Iber C (2002) Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 11:265–272CrossRefPubMed Boland LL, Shahar E, Iber C (2002) Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 11:265–272CrossRefPubMed
31.
go back to reference American Diabetes Association (2017) Standards of medical care in diabetes-2017. Diabetes Care 40:S1–S142CrossRef American Diabetes Association (2017) Standards of medical care in diabetes-2017. Diabetes Care 40:S1–S142CrossRef
32.
go back to reference Tangwongchai S, Charenboon T, Phanasathit M et al (2009) The validity of thai version of the montreal cognitive assessment (MoCA-T). Dement Neuropsychol 3:172 Tangwongchai S, Charenboon T, Phanasathit M et al (2009) The validity of thai version of the montreal cognitive assessment (MoCA-T). Dement Neuropsychol 3:172
33.
go back to reference Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
34.
go back to reference Trangkasombat U, Larpboonsarp V, Havanond P (1997) CES-D as a screen for depression in adolescents. J Psychiatr Assoc Thail 42:2–13 Trangkasombat U, Larpboonsarp V, Havanond P (1997) CES-D as a screen for depression in adolescents. J Psychiatr Assoc Thail 42:2–13
35.
go back to reference Ploylermsang C (2005) Contructive validity of the CES-D depression sclae among student. IJPS 1:25–39 Ploylermsang C (2005) Contructive validity of the CES-D depression sclae among student. IJPS 1:25–39
37.
go back to reference Zou D, Grote L, Peker Y, Lindblad U, Hedner J (2006) Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography. Sleep 29:367–374CrossRefPubMed Zou D, Grote L, Peker Y, Lindblad U, Hedner J (2006) Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography. Sleep 29:367–374CrossRefPubMed
42.
go back to reference Blackwell T, Yaffe K, Ancoli-Israel S et al (2006) Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol Ser A Biol Sci Med Sci 61:405–410CrossRef Blackwell T, Yaffe K, Ancoli-Israel S et al (2006) Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol Ser A Biol Sci Med Sci 61:405–410CrossRef
Metadata
Title
The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes
Authors
Sunee Saetung
Hataikarn Nimitphong
Nantaporn Siwasaranond
Rungtip Sumritsopak
Panitha Jindahra
Orapitchaya Krairit
Ammarin Thakkinstian
Thunyarat Anothaisintawee
Sirimon Reutrakul
Publication date
01-09-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 9/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1166-3

Other articles of this Issue 9/2018

Acta Diabetologica 9/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.